Long-term survival after kidney transplantation

S Hariharan, AK Israni… - New England Journal of …, 2021 - Mass Medical Soc
Long-Term Survival after Kidney Transplantation This review discusses demographics,
survival, and risks in kidney transplantation since the mid-1990s. It addresses postoperative …

Development of a vaccine against human cytomegalovirus: advances, barriers, and implications for the clinical practice

S Scarpini, F Morigi, L Betti, A Dondi, C Biagi, M Lanari - Vaccines, 2021 - mdpi.com
Human cytomegalovirus (hCMV) is one of the most common causes of congenital infection
in the post-rubella era, representing a major public health concern. Although most cases are …

Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection

EC Semmes, IG Miller, CE Wimberly… - The Journal of …, 2022 - Am Soc Clin Investig
Human cytomegalovirus (HCMV) is the most common congenital infection and a leading
cause of stillbirth, neurodevelopmental impairment, and pediatric hearing loss worldwide …

[HTML][HTML] ADCC-activating antibodies correlate with decreased risk of congenital human cytomegalovirus transmission

EC Semmes, IG Miller, N Rodgers, CT Phan, JH Hurst… - JCI insight, 2023 - ncbi.nlm.nih.gov
Human cytomegalovirus (HCMV) is the most common vertically transmitted infection
worldwide, yet there are no vaccines or therapeutics to prevent congenital HCMV (cCMV) …

[HTML][HTML] Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer

M Zehner, M Alt, A Ashurov, JA Goldsmith, R Spies… - Immunity, 2023 - cell.com
Human cytomegalovirus (HCMV) can cause severe diseases in fetuses, newborns, and
immunocompromised individuals. Currently, no vaccines are approved, and treatment …

Lessons from acquired natural immunity and clinical trials to inform next-generation human cytomegalovirus vaccine development

X Hu, HY Wang, CE Otero, JA Jenks… - Annual review of …, 2022 - annualreviews.org
Human cytomegalovirus (HCMV) infection, the most common cause of congenital disease
globally, affecting an estimated 1 million newborns annually, can result in lifelong sequelae …

Novel monoclonal antibody-based therapies: Implications for the treatment and prevention of HCMV disease

M Nuévalos, E García-Ríos, FJ Mancebo… - Trends in …, 2023 - cell.com
Human cytomegalovirus (HCMV) is an important pathogen worldwide. Although HCMV
infection is often asymptomatic in immunocompetent individuals, it can cause severe or even …

Neutralizing antibodies limit cell-associated spread of human cytomegalovirus in epithelial cells and fibroblasts

N Reuter, B Kropff, WJ Britt, M Mach, M Thomas - Viruses, 2022 - mdpi.com
Human cytomegalovirus (HCMV) can cause severe clinical disease in immunocompromised
individuals, such as allograft recipients and infants infected in utero. Neutralizing activity of …

Re-Emerging COVID-19: Controversy of its zoonotic origin, risks of severity of reinfection and management

B Chala, T Tilaye, G Waktole - International journal of general …, 2023 - Taylor & Francis
The re-emergence of COVID-19 has sparked controversy around its zoonotic origin,
management strategies, risks posed by the virus, and the severity of reinfection. While it is …

Cytomegalovirus Pneumonia in Inflammatory Bowel Disease: Literature Review and Clinical Recommendations

K Ren, C Yong, Y Wang, H Wei, K Zhao… - Infection and Drug …, 2023 - Taylor & Francis
Aim The objective was to elucidate the correlation between CMVP and immunosuppressive
therapy in IBD patients, we hope this review could expand on the significance of CMV as an …